(MENAFN- GlobeNewsWire - Nasdaq) Global Comparator Drug Sourcing Market to Grow at 8.47% CAGR as Demand for Effective, Compliant, and On-Time Clinical Trial Supply Solutions Increases. Austin, Texas, ...
Austin, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- As per SNS Insider, the Comparator Drug Sourcing Market was valued at USD 1.42 billion in 2025 and is projected to reach USD 2.72 billion by 2033, ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. These highlights were written by the reporters and editors ...
ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Please provide your email address to receive an email when new articles are posted on . The sterile, preservative-free formulation is the generic equivalent of Restasis. In patients treated with the ...
Monday - Friday, 11:00 - 12:00 SIN/HK | 0500 - 06:00 CET Shreehas Tambe, CEO & managing director of Biocon Biologics, discusses the way that US tariff & manufacturing policy affects India's ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
Several lots of a generic ADHD medication used by millions are under recall because users may not be getting the full benefit. Sun Pharmaceutical Industries issued the voluntary, nationwide recall for ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how hard that will be for generic medicines. Dr. Reddy’s, an Indian generic ...
The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...